HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?

AuthorsStephen J Kish
JournalMovement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 18 Issue 11 Pg. 1219-23 (Nov 2003) ISSN: 0885-3185 [Print] United States
PMID14639660 (Publication Type: Comment, Editorial, Review)
Chemical References
  • Carrier Proteins
  • Hallucinogens
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Receptors, Dopamine
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • N-Methyl-3,4-methylenedioxyamphetamine
Topics
  • Brain (blood supply, drug effects, physiopathology)
  • Carrier Proteins (drug effects)
  • Hallucinogens (adverse effects)
  • Humans
  • Membrane Glycoproteins (drug effects)
  • Membrane Transport Proteins
  • N-Methyl-3,4-methylenedioxyamphetamine (adverse effects)
  • Nerve Tissue Proteins
  • Parkinson Disease, Secondary (chemically induced, diagnosis, physiopathology)
  • Receptors, Dopamine (drug effects)
  • Serotonin Plasma Membrane Transport Proteins
  • Tomography, Emission-Computed
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: